109 related articles for article (PubMed ID: 19024325)
1. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
[TBL] [Abstract][Full Text] [Related]
2. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer.
Nagata T; Sakakura C; Komiyama S; Miyashita A; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Otsuji E
Anticancer Res; 2011 Feb; 31(2):495-500. PubMed ID: 21378329
[TBL] [Abstract][Full Text] [Related]
3. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
Mărgăritescu C; Pirici D; Simionescu C; Stepan A
Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
[TBL] [Abstract][Full Text] [Related]
4. CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma.
He A; Yang X; Huang Y; Feng T; Wang Y; Sun Y; Shen Z; Yao Y
J Cell Biochem; 2015 Aug; 116(8):1719-29. PubMed ID: 25736420
[TBL] [Abstract][Full Text] [Related]
5. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
[TBL] [Abstract][Full Text] [Related]
6. Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma.
Sun Y; Han J; Lu Y; Yang X; Fan M
Oral Dis; 2012 Mar; 18(2):169-77. PubMed ID: 22023137
[TBL] [Abstract][Full Text] [Related]
7. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
[TBL] [Abstract][Full Text] [Related]
8. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
[TBL] [Abstract][Full Text] [Related]
9. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
Galizia G; Gemei M; Del Vecchio L; Zamboli A; Di Noto R; Mirabelli P; Salvatore F; Castellano P; Orditura M; De Vita F; Pinto M; Pignatelli C; Lieto E
Arch Surg; 2012 Jan; 147(1):18-24. PubMed ID: 22250106
[TBL] [Abstract][Full Text] [Related]
10. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
11. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
[TBL] [Abstract][Full Text] [Related]
12. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
Xu YH; Zhang GB; Wang JM; Hu HC
Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
14. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
Yu D; Jin CS; Chen O; Wen LJ; Gao LF
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
[TBL] [Abstract][Full Text] [Related]
15. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
[TBL] [Abstract][Full Text] [Related]
16. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
Horst D; Kriegl L; Engel J; Kirchner T; Jung A
Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
[TBL] [Abstract][Full Text] [Related]
18. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
[TBL] [Abstract][Full Text] [Related]
19. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
20. The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell line A549.
Zhang HZ; Lin XG; Hua P; Wang M; Ao X; Xiong LH; Wu C; Guo JJ
Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1350-8. PubMed ID: 20937222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
